EnvistaNVST
About: Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.
Employees: 12,800
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
142% more call options, than puts
Call options by funds: $2.14M | Put options by funds: $886K
36% more repeat investments, than reductions
Existing positions increased: 135 | Existing positions reduced: 99
2% less funds holding
Funds holding: 297 [Q1] → 290 (-7) [Q2]
5.6% less ownership
Funds ownership: 115.29% [Q1] → 109.69% (-5.6%) [Q2]
19% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 37
26% less capital invested
Capital invested by funds: $4.23B [Q1] → $3.13B (-$1.1B) [Q2]
Research analyst outlook
8 Wall Street Analysts provided 1 year price targets over the past 3 months
8 analyst ratings
Wells Fargo Vik Chopra 0% 1-year accuracy 0 / 4 met price target | 9%upside $20 | Equal-Weight Initiated | 8 Oct 2024 |
Evercore ISI Group Elizabeth Anderson 40% 1-year accuracy 12 / 30 met price target | 26%upside $23 | Outperform Maintained | 23 Sept 2024 |
B of A Securities Michael Cherny 41% 1-year accuracy 12 / 29 met price target | 4%upside $19 | Buy Maintained | 8 Aug 2024 |
Evercore ISI Group Elizabeth Anderson 40% 1-year accuracy 12 / 30 met price target | 1%downside $18 | Outperform Maintained | 8 Aug 2024 |
JP Morgan Rachel Vatnsdal 64% 1-year accuracy 14 / 22 met price target | 12%downside $16 | Neutral Downgraded | 8 Aug 2024 |